Intensity Average Payables from 2010 to 2026
| INTS Stock | 0.41 0.03 7.89% |
Average Payables | First Reported 2010-12-31 | Previous Quarter 177.8 K | Current Value 158.1 K | Quarterly Volatility 10.4 K |
Check Intensity Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intensity Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 379.2 K, Interest Income of 379.2 K or Depreciation And Amortization of 21.4 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 7.93. Intensity financial statements analysis is a perfect complement when working with Intensity Therapeutics Valuation or Volatility modules.
Intensity | Average Payables | Build AI portfolio with Intensity Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intensity Stock Analysis
When running Intensity Therapeutics' price analysis, check to measure Intensity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intensity Therapeutics is operating at the current time. Most of Intensity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Intensity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intensity Therapeutics' price. Additionally, you may evaluate how the addition of Intensity Therapeutics to your portfolios can decrease your overall portfolio volatility.